Industry News
Study links rare genetic mutation to severe neurological disorder
Research at Karl Landsteiner University of Health Sciences offers new insight in brain connectivity and development
Research at Karl Landsteiner University of Health Sciences offers new insight in brain connectivity and development
Learn how BioApp Solutions enhances liquid handling efficiency with INTEGRA Biosciences' pipettes
The PATHWAY HER2 (4B5) test helps identify patients with previously treated, unresectable or metastatic HER2-positive biliary tract cancer (BTC) who may be eligible for treatment with ZIIHERA
The expansion enhances Abzena’s extensive bioassay offering, providing customers with a more comprehensive, streamlined, and cost-effective way to access critical data faster